Learn how SGLT2 inhibitor dapagliflozin improves MASH outcomes, with potential clinical use beyond diabetes care.

Discover a recent study where the authors propose a strategic push to double the diagnostic rate of at-risk MASH by 2030.

AI model GPT-4o accurately extracts brain circuit data from scientific literature, offering a faster, reliable way to advance ...

New Ipsos data shows that while 58% of UK adults are willing to join clinical trials, this drops to 41% among ethnic minority ...

Study finds percutaneous balloon dilation offers better long-term outcomes than surgery for severe benign biliary strictures, particularly Bismuth-Strasberg type E4 and E5 cases.

Real-world 48-week data from the MONITOR-PsA cohort shows that a treat-to-target strategy in psoriatic arthritis can be successfully implemented in routine UK clinical practice.